دورية أكاديمية

Characteristics and Outcomes of Stem Cell Transplant Patients during the COVID-19 Era: A Systematic Review and Meta-Analysis.

التفاصيل البيبلوغرافية
العنوان: Characteristics and Outcomes of Stem Cell Transplant Patients during the COVID-19 Era: A Systematic Review and Meta-Analysis.
المؤلفون: Kamal, Mona, Baudo, Massimo, Joseph, Jacinth, Geng, Yimin, Mohamed, Omnia, Rahouma, Mohamed, Greenbaum, Uri
المصدر: Healthcare (2227-9032); Mar2024, Vol. 12 Issue 5, p530, 14p
مصطلحات موضوعية: STEROID drugs, HEMATOPOIETIC stem cell transplantation, HYDROXYCHLOROQUINE, ANTIBIOTICS, TREATMENT effectiveness, META-analysis, SYSTEMATIC reviews, ANTIVIRAL agents, MEDLINE, MEDICAL databases, CONFIDENCE intervals, ONLINE information services, COVID-19 pandemic, IMMUNOSUPPRESSION, HEALTH care teams, IMMUNOCOMPETENCE
مستخلص: This systematic review and meta-analysis aims to identify the outcomes of stem cell transplant (SCT) patients during the COVID-19 era. Pooled event rates (PER) were calculated, and meta-regression was performed. A random effects model was utilized. In total, 36 eligible studies were included out of 290. The PER of COVID-19-related deaths and COVID-19-related hospital admissions were 21.1% and 55.2%, respectively. The PER of the use of hydroxychloroquine was 53.27%, of the receipt of immunosuppression it was 39.4%, and of the use of antivirals, antibiotics, and steroids it was 71.61%, 37.94%, and 18.46%, respectively. The PER of the time elapsed until COVID-19 infection after SCT of more than 6 months was 85.3%. The PER of fever, respiratory symptoms, and gastrointestinal symptoms were 70.9, 76.1, and 19.3%, respectively. The PER of acute and chronic GvHD were 40.2% and 60.9%, respectively. SCT patients are at a higher risk of severe COVID-19 infection and mortality. The use of dexamethasone improves the survival of hospitalized SCT patients with moderate to severe COVID-19 requiring supplemental oxygen or ventilation. The SCT patient group is a heterogeneous group with varying characteristics. The quality of reporting on these patients when infected with COVID-19 is not uniform and further prospective or registry studies are needed to better guide clinical care in this unique setting. [ABSTRACT FROM AUTHOR]
Copyright of Healthcare (2227-9032) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:22279032
DOI:10.3390/healthcare12050530